Rikshospitalet University Hospital
Oslo, 0027, Norway
NCT Number: NCT00248690
The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Oslo, 0027, Norway
In this study SAH-patients are randomized to treatment based on international standard care (ICP/CPP guided therapy) or intracranial compliance (ICP mean wave amplitude) guided therapy in addition to ICP/CPP guided therapy. Main outcome variables are survival and neurological outcome after 3 and 12 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Appropriate measures when ICP mean wave amplitude is to high, e.g. CSF drainage
Time frame: 3 and 12 months
Time frame: Hospital stay
Oslo University Hospital
Other
Intracranial Pressure (ICP) Versus Intracranial Compliance (ICC) Guided Management in Subarachnoid Hemorrhage; - a Prospective, Randomized Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03761654
Brain Diseases, Cardiomyopathies
Bordeaux, France
View Trial DetailsNCT02172703
Brain Diseases, Brain Injuries
Aarau, Canton of Aargau, Switzerland
View Trial DetailsNCT00954551
Brain Diseases, Cardiovascular Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06646484
Brain Diseases, Cardiovascular Diseases
Lyon, France
View Trial Details